Posted in | News | Remote Monitoring

Clinical Study by BIOTRONIK Reveals Novel Technique to Detect Cardiovascular Disease

BIOTRONIK has announced that the results of a clinical research conducted by Home Monitoring in Cardiac Resynchronization Therapy (Home-CARE) have been published in the European Journal of Heart Failure.

Biotronik Sensors

The Home-CARE study was conducted on 515 patients and was conducted across many centres internationally. The study aimed at creating an automated algorithm that took multiple parameters related to cardiovascular disease that was provided by BIOTRONIK Home Monitoring System into consideration and dynamically foresee death and hospitalization for patients suffering from the disease. The main parameters that were considered for analysing the cardiovascular status of the heart failure patients were mean heart rate, heart rate variability and patient activity. By using of all these parameters together, 65.4% sensitivity was observed in identification of cardiovascular death and hospitalizations with a specificity of 99.5%.

Professor Stefan Sack explained that the study believed that by coming up with an algorithm which took into consideration several parameters, the overall risk ability could be improved with patients having implanted cardiac devices. This algorithm was the brain child of BIOTRONIK which was used for early detection of cardiovascular events based on the data from the Home Monitoring system. The Home Monitoring system from BIOTRONIK is capable of transmitting accurate, real-time data by remotely monitoring the diagnostic data. By using this data for research and development purposes it is possible to design advanced diagnostic algorithms that includes novel sensor technology and to accurately study their influence on clinical administration, patient outcomes and health economic burden. The Vice President of Global Marketing at BIOTRONIK, Marlou Janssen, believes that the new algorithm designed by them will prove useful in building HF predictor applications in future and enhance the patient management systems through BIOTRONIK Home Monitoring.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    BIOTRONIK. (2019, February 20). Clinical Study by BIOTRONIK Reveals Novel Technique to Detect Cardiovascular Disease. AZoRobotics. Retrieved on June 25, 2024 from https://www.azorobotics.com/News.aspx?newsID=1991.

  • MLA

    BIOTRONIK. "Clinical Study by BIOTRONIK Reveals Novel Technique to Detect Cardiovascular Disease". AZoRobotics. 25 June 2024. <https://www.azorobotics.com/News.aspx?newsID=1991>.

  • Chicago

    BIOTRONIK. "Clinical Study by BIOTRONIK Reveals Novel Technique to Detect Cardiovascular Disease". AZoRobotics. https://www.azorobotics.com/News.aspx?newsID=1991. (accessed June 25, 2024).

  • Harvard

    BIOTRONIK. 2019. Clinical Study by BIOTRONIK Reveals Novel Technique to Detect Cardiovascular Disease. AZoRobotics, viewed 25 June 2024, https://www.azorobotics.com/News.aspx?newsID=1991.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.